Evidence map›Paper›PMID 38591862›Full record

ArticleInflammatory bowel diseases2024

Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy.

Catherine Rowan, Fiona Yeaman, Kenneth Ernest-Suarez, Marie-Louise Martin, Remo Panaccione, Tushar Shukla, Matt Grossi, Meghan Vlasschaert, Kerri Novak, Cynthia Seow

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Inflammatory bowel diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Catherine RowanInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.
Fiona YeamanInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.
Kenneth Ernest-SuarezInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.ORCID 0000-0001-8360-8190
Marie-Louise MartinInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.
Remo PanaccioneInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.ORCID 0000-0002-5247-940X
Tushar ShuklaInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.
Matt GrossiObstetrics and Gynecology, Rockyview General Hospital, University of Calgary, Calgary, Canada.
Meghan VlasschaertGeneral Internal Medicine and Obstetric Medicine, Educational Director, OBIM, University of Calgary, Calgary, Canada.
Kerri NovakInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.ORCID 0000-0003-4164-7321
Cynthia SeowInflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Canada.ORCID 0000-0002-1551-9054

Funding

Alberta Children's Hospital Research Institute
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colitis, UlcerativePiperidinesPregnancy ComplicationsPyrimidinesAdultFemaleHumansJanus Kinase InhibitorsPregnancyJanus Kinase InhibitorsPiperidinesPyrimidinestofacitinibpregnancytofacitinibulcerative colitis

Identifiers

PMID38591862
PMCPMC11063541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.